VI
ANIP icon

Versor Investments’s ANI Pharmaceuticals ANIP Stock Holding History

Versor Investments’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,745
Closed -$328K – 718
2024
Q1 		$328K Buy
4,745
+900
+23% +$54.3K 0.07% 468
2023
Q4 		$212K Hold
3,845
– – 0.04% 644
2023
Q3 		$223K Sell
3,845
-1,407
-27% -$81.2K 0.05% 569
2023
Q2 		$283K Buy
+5,252
New +$233K 0.05% 441

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Versor Investments's ANIP Position: Q2 2024 in Review

Versor Investments sold out of ANI Pharmaceuticals (ANIP) in Q2 2024, closing a stake of 4,745 shares — an estimated $328K sold.

Versor Investments first reported a position in ANIP in Q2 2023 and held it in 4 quarters. The position peaked at $328K in Q1 2024. 201 funds tracked by Wall St. Rank hold ANIP as of Q2 2024.

  • Versor Investments reported no remaining ANI Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Versor Investments sold 4,745 ANI Pharmaceuticals shares in Q2 2024, an estimated $328K.
  • Versor Investments first reported a position in ANI Pharmaceuticals in Q2 2023 and held it in 4 quarters.
  • Versor Investments's ANI Pharmaceuticals position peaked at $328K in Q1 2024.
  • 201 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2024.

Based on Versor Investments's 13F filing for Q2 2024, filed 1 Aug 2024.